Health & Welfare
Studies seek oral delivery of RNAi-based therapeutics for shrimp
Therapeutics to harness an active RNA interference (RNAi) response in shrimp and protect against viral diseases could provide benefits to aquaculture.
Innovation & Investment
World’s first fully integrated Pacific white shrimp genomic selection program established in Ecuador
The story behind the first wide-scale application of genomic selection at commercial scale for shrimp broodstock at Texcumar S.A.